MarketBeat provided a consensus rating for Quest Diagnostics, and Truist Financial raised its price target for the company.
4 reports, 1 independent
Updated Sep 23
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided a consensus rating for Quest Diagnostics, and Truist Financial raised its price target for the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Quest Diagnostics
medical research company
-
MarketBeat
American personal finance blog
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- Corning saw rating changes and price target adjustments from Morgan Stanley and Truist Financial, alongside increased shareholding by the Czech National Bank.
- Retailers like Kroger and Walmart intensify competition in the grocery market, while Erste Group and Truist Financial report market movements.
Related events
- MarketBeat provided consensus ratings for MACOM as Susquehanna dropped its price objective and Needham & Company increased its target and gave a buy rating.
- MarketBeat provided a consensus rating and target price for Carriage Services, Inc., following a price target set by Raymond James Financial.
- Benchmark initiated coverage with a buy rating, while MarketBeat provided consensus data and Citigroup reduced its target price.
- MarketBeat provided consensus rating data on Navios Maritime Partners LP, while Jefferies Financial Group assumed coverage and issued a buy rating.
- Cantor Fitzgerald increased its price target and rating for Hyperliquid Strategies, while MarketBeat provided consensus rating data.
Coverage
Newest first; wire copies grouped- dailypolitical.comTruist Financial Forecasts Strong Price Appreciation for Quest Diagnostics (NYSE:DGX) Stock